HopeStage
Back to all studies
TerminatedNCT01309581

Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression

Medication studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
New YorkSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateApril 2010
Recruitment status
Terminated
Enrollment listed in the registry
3
Sponsor
James Murrough
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01309581
Official title
Show the full official title

Ketamine Anesthesia to Enhance Efficacy and Tolerability of Electroconvulsive Therapy in Patients With Unipolar or Bipolar Depression

Recruitment & locations

Terminated

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is James Murrough.

Does this study involve medication?

Yes. The study involves medication, including ketamine and Methohexital.

Who can participate?

This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies